When NSCLC patients were divided into younger and older groups (different studies chose different cutoff points for age, namely 60, 62, 65, etc.), no significant difference existed in the rates of EGFR mutation among different groups [4,7,8]. Here, EGFR is linked to non-small cell lung carcinoma.